Another important aspect is mutations in the genes of the HER family ("human epidermal growth factor receptors"), which consists of HER1, HER2, HER3 and HER4. Weng et al. have shown that loss of expression of the HER2 gene is frequently observed in chRCC. Here, EGFR is linked to chromophobe renal cell carcinoma.